“Tanshinone IIA Attenuates Interleukin-17A-Induced Systemic Sclerosis Patient-Derived Dermal Vascular Smooth Muscle Cell Activation via Inhibition of the Extracellular Signal-Regulated Kinase Signaling Pathway”. Clinics, vol. 70, no. 4, Apr. 2015, pp. 250-6, https://doi.org/10.6061/clinics/2015(04)06.